Atlassian Q2: Ignore Market's Short-Term Pessimism

Atlassian (NASDAQ:TEAM) reported a strong Q4 FY25, exceeding revenue and operating margin expectations with 22% YoY growth to $1.38B, driven by robust Cloud segment performance and record enterprise deal closures. However, the company issued softer-than-expected FY26 revenue guidance of 18% growth and anticipates margin contraction to 24%, attributing this to macroeconomic caution and increased strategic investments in AI, System of Work, and enterprise solutions. Despite significant year-to-date multiple contraction, management reiterated confidence in achieving its FY29 $10B revenue target and 25%+ operating margins from FY27, leading the analyst to reiterate a 'buy' rating with a $223 price target, viewing the current valuation as a long-term opportunity.

Analysis

Atlassian (TEAM) has presented a dichotomous financial picture, reporting strong Q4 FY25 results that surpassed expectations while issuing conservative forward guidance for FY26. The company's revenue accelerated to $1.38 billion, a 22% year-over-year increase, driven by 26% growth in its Cloud segment and a 17% rise in Data Center revenue. Non-GAAP operating margins also beat guidance at 24.3%. This performance is underpinned by strong execution on strategic priorities, evidenced by a 2x year-over-year increase in deals exceeding $1 million in annual contract value and a 40% quarter-over-quarter growth in AI monthly active users to 2.3 million. However, the market has reacted negatively to FY26 guidance, which projects a slowdown in revenue growth to 18% and a margin contraction to 24% due to increased R&D and sales investments. This guidance appears cautious, especially when contrasted with the 29% year-over-year growth in current Remaining Performance Obligations (cRPO). The primary conflict for investors is the market's focus on this short-term guidance, which has led to a 45% contraction in the forward price-to-earnings multiple year-to-date, despite management reiterating its long-term targets of $10 billion in revenue by FY29 and operating margins exceeding 25% from FY27 onwards.

Key Decisions for Investors

• Investors with a long-term horizon could consider the significant multiple contraction as a potential entry point, capitalizing on the market's negative reaction to conservative short-term guidance while fundamentals and long-term targets remain firm.
• Monitor leading indicators such as cRPO growth, enterprise deal velocity, and AI adoption rates in subsequent quarters to validate the thesis that management's FY26 guidance is overly cautious and that strategic investments are translating into durable growth.
• The investment case is predicated on management's execution; therefore, any deviation from the path toward achieving its FY27 operating margin target of over 25% should be viewed as a significant risk to the long-term bullish thesis.